# MESALAMINE
> **ANDA209970** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-05-06
## Drug
- **FDA Application Number:** ANDA209970
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** Mesalamine
- **Active ingredients:** MESALAMINE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2022-05-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209970)
---
*AI Analytics · CC0 1.0*